These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31011522)

  • 21. Long Noncoding RNA UCA1 Regulates PRL-3 Expression by Sponging MicroRNA-495 to Promote the Progression of Gastric Cancer.
    Cao Y; Xiong JB; Zhang GY; Liu Y; Jie ZG; Li ZR
    Mol Ther Nucleic Acids; 2020 Mar; 19():853-864. PubMed ID: 31982772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
    Deng Y; Zhao F; Zhang Z; Sun F; Wang M
    Cancer Biother Radiopharm; 2018 Nov; 33(9):365-372. PubMed ID: 29989838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-associated fibroblasts enhance cell proliferation and metastasis of colorectal cancer SW480 cells by provoking long noncoding RNA UCA1.
    Jahangiri B; Khalaj-Kondori M; Asadollahi E; Sadeghizadeh M
    J Cell Commun Signal; 2019 Mar; 13(1):53-64. PubMed ID: 29948578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA UCA1 promotes cell progression by acting as a competing endogenous RNA of ATF2 in prostate cancer.
    Zhang S; Dong X; Ji T; Chen G; Shan L
    Am J Transl Res; 2017; 9(2):366-375. PubMed ID: 28337266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer.
    Li Z; Niu H; Qin Q; Yang S; Wang Q; Yu C; Wei Z; Jin Z; Wang X; Yang A; Chen X
    Mol Ther Nucleic Acids; 2019 Sep; 17():92-101. PubMed ID: 31234009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HES5 Activates Long Noncoding RNA UCA1 to Induce Colorectal Cancer Progression by Modulating miR-185/NOTCH3 Signaling.
    Wang M; Zheng Q; Zhao Z; Deng H; Zhang Q; Yao H
    Gastroenterol Res Pract; 2021; 2021():7249818. PubMed ID: 34733326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer.
    Chen X; Wang Z; Tong F; Dong X; Wu G; Zhang R
    Mol Ther Nucleic Acids; 2020 Mar; 19():643-653. PubMed ID: 31951852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway.
    Dai Q; Zhang T; Pan J; Li C
    J Cancer; 2020; 11(13):3882-3892. PubMed ID: 32328192
    [No Abstract]   [Full Text] [Related]  

  • 29. Long Noncoding RNA GAS5 Suppresses Cell Growth and Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating the miR-221/ARHI Pathway.
    Ye K; Wang S; Zhang H; Han H; Ma B; Nan W
    J Cell Biochem; 2017 Dec; 118(12):4772-4781. PubMed ID: 28519068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of lncRNA UCA1 facilitates apoptosis and reduces proliferation in multiple myeloma via regulation of the miR-1271-5p/HGF axis.
    Yang Y; Chen L
    J Chin Med Assoc; 2019 Sep; 82(9):699-709. PubMed ID: 31356563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA UCA1 is necessary for TGF-β-induced epithelial-mesenchymal transition and stemness via acting as a ceRNA for Slug in glioma cells.
    Li Z; Liu H; Zhong Q; Wu J; Tang Z
    FEBS Open Bio; 2018 Nov; 8(11):1855-1865. PubMed ID: 30410864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA UCA1 indicates an unfavorable prognosis and promotes tumorigenesis via regulating AKT/GSK-3β signaling pathway in cholangiocarcinoma.
    Xu Y; Yao Y; Leng K; Li Z; Qin W; Zhong X; Kang P; Wan M; Jiang X; Cui Y
    Oncotarget; 2017 Nov; 8(56):96203-96214. PubMed ID: 29221199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of long noncoding RNA urothelial carcinoma associated 1 inhibits colorectal cancer cell proliferation and promotes apoptosis via modulating autophagy.
    Song F; Li L; Liang D; Zhuo Y; Wang X; Dai H
    J Cell Physiol; 2019 May; 234(5):7420-7434. PubMed ID: 30362538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma.
    Li Q; Pan X; Wang X; Jiao X; Zheng J; Li Z; Huo Y
    Oncotarget; 2017 Dec; 8(63):106648-106660. PubMed ID: 29290978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. lncRNA UCA1 Functions as a ceRNA to Promote Prostate Cancer Progression via Sponging miR143.
    Yu Y; Gao F; He Q; Li G; Ding G
    Mol Ther Nucleic Acids; 2020 Mar; 19():751-758. PubMed ID: 31954329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis.
    Yang Y; Jiang Y; Wan Y; Zhang L; Qiu J; Zhou S; Cheng W
    Tumour Biol; 2016 Aug; 37(8):10633-41. PubMed ID: 26867765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway.
    Li HJ; Sun XM; Li ZK; Yin QW; Pang H; Pan JJ; Li X; Chen W
    Cell Physiol Biochem; 2017; 43(6):2548-2561. PubMed ID: 29130995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA UCA1 accelerates osteosarcoma progression via miR-145 and Wnt/β-catenin pathway.
    Guan J; He J; Liao S; Wu Z; Lin X; Liu B; Qin X; Tan J; Huang C; Yuan Z; Mo H
    Am J Transl Res; 2022; 14(9):6029-6042. PubMed ID: 36247254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA LeXis promotes osteosarcoma growth through upregulation of CTNNB1 expression.
    Wang G; Cui T; Sun L; Peng N; Yang C
    Am J Cancer Res; 2017; 7(7):1577-1587. PubMed ID: 28744406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UCA1 promotes cell viability, proliferation and migration potential through UCA1/miR-204/CCND2 pathway in primary cystitis glandularis cells.
    Zhou X; Cui Y; Chen J; Li C; Chen F; Chen X; Ou Z; Cheng X; Ren W; Li H; Zu X; Liu N
    Biomed Pharmacother; 2019 Jun; 114():108872. PubMed ID: 30999112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.